| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

* From the Department of Anesthesiology (B1), Graduate School of Medicine, Chiba University, Chiba, Japan, and
the Nuffield Department Of Anaesthetics University of Oxford, Oxford, United Kingdom.
Dr. Rie Kato, Department of Anesthesiology (B1), Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan. Phone: +81 43-2262155; Fax: +81 43-2262156; E-mail: rie.kato{at}anesth01.m.chiba-u.ac.jp
Purpose: The aim of this review of the literature was to evaluate the effectiveness of anesthetics in protecting the heart against myocardial ischemia-reperfusion injury.
Source: Articles were obtained from the Medline database (1980-, search terms included heart, myocardium, coronary, ischemia, reperfusion injury, infarction, stunning, halothane, enflurane, desflurane, isoflurane, sevoflurane, opioid, morphine, fentanyl, alfentanil sufentanil, pentazocine, buprenorphine, barbiturate, thiopental, ketamine, propofol, preconditioning, neutrophil adhesion, free radical, antioxidant and calcium).
Principal findings: Protection by volatile anesthetics, morphine and propofol is relatively well investigated. It is generally agreed that these agents reduce the myocardial damage caused by ischemia and reperfusion. Other anesthetics which are often used in clinical practice, such as fentanyl, ketamine, barbiturates and benzodiazepines have been much less studied, and their potential as cardioprotectors is currently unknown. There are some proposed mechanisms for protection by anesthetic agents: ischemic preconditioning-like effect, interference in the neutrophil/platelet-endothelium interaction, blockade of Ca2+ overload to the cytosolic space and antioxidant-like effect. Different anesthetics appear to have different mechanisms by which protection is exerted. Clinical applicability of anesthetic agent-induced protection has yet to be explored.
Conclusion: There is increasing evidence of anesthetic agent-induced protection. At present, isoflurane, sevoflurane and morphine appear to be most promising as preconditioning-inducing agents. After the onset of ischemia, propofol could be selected to reduce ischemia-reperfusion injury. Future clinical application depends on the full elucidation of the underlying mechanisms and on clinical outcome trials.
This article has been cited by other articles:
![]() |
S. Lorsomradee, S. Cromheecke, S. Lorsomradee, and S. G De Hert Cardioprotection with Volatile Anesthetics in Cardiac Surgery Asian Cardiovasc Thorac Ann, June 1, 2008; 16(3): 256 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sanchez-Conde, J. M. Rodriguez-Lopez, J. L. Nicolas, F. S. Lozano, F. J. Garcia-Criado, C. Cascajo, R. Gonzalez-Sarmiento, and C. Muriel The Comparative Abilities of Propofol and Sevoflurane to Modulate Inflammation and Oxidative Stress in the Kidney After Aortic Cross-Clamping Anesth. Analg., February 1, 2008; 106(2): 371 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wang, J. Radhakrishnan, I. M. Ayoub, J. D. Kolarova, D. M. Taglieri, and R. J. Gazmuri Limiting sarcolemmal Na+ entry during resuscitation from ventricular fibrillation prevents excess mitochondrial Ca2+ accumulation and attenuates myocardial injury J Appl Physiol, July 1, 2007; 103(1): 55 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Chambers Oxidative stress injury during cardiac surgery: How important is it? Cardiovasc Res, March 1, 2007; 73(4): 626 - 628. [Full Text] [PDF] |
||||
![]() |
M. A. Lessa and E. Tibirica Pharmacologic Evidence for the Involvement of Central and Peripheral Opioid Receptors in the Cardioprotective Effects of Fentanyl Anesth. Analg., October 1, 2006; 103(4): 815 - 821. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Symons and P. S. Myles Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis Br. J. Anaesth., August 1, 2006; 97(2): 127 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Rodriguez-Lopez, P. Sanchez-Conde, F. S. Lozano, J. L. Nicolas, F. J. Garcia-Criado, C. Cascajo, and C. Muriel Laboratory investigation: Effects of propofol on the systemic inflammatory response during aortic surgery: [Essai en laboratoire : les effets du propofol sur la reaction inflammatoire generalisee pendant une operation de l'aorte]. Can J Anesth, July 1, 2006; 53(7): 701 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. H. Lim, A. P. Halestrap, G. D. Angelini, and M.-S. Suleiman Propofol Is Cardioprotective in a Clinically Relevant Model of Normothermic Blood Cardioplegic Arrest and Cardiopulmonary Bypass Experimental Biology and Medicine, June 1, 2005; 230(6): 413 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Malagon, K. Hogenbirk, J. van Pelt, M. G. Hazekamp, and J. G. Bovill Effect of three different anaesthetic agents on the postoperative production of cardiac troponin T in paediatric cardiac surgery Br. J. Anaesth., June 1, 2005; 94(6): 805 - 809. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dworschak, D. Breukelmann, and J. D. Hannon The Impact of Isoflurane During Simulated Ischemia/Reoxygenation on Intracellular Calcium, Contractile Function, and Arrhythmia in Ventricular Myocytes Anesth. Analg., November 1, 2004; 99(5): 1302 - 1307. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zaugg, M. C. Schaub, and P. Foex Myocardial injury and its prevention in the perioperative setting Br. J. Anaesth., July 1, 2004; 93(1): 21 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kelleher and J. Gothard Editorial II: Anaesthesia for off-pump coronary artery surgery Br. J. Anaesth., March 1, 2004; 92(3): 324 - 326. [Full Text] [PDF] |
||||
![]() |
M. Joyeux-Faure, C. Arnaud, D. Godin-Ribuot, and C. Ribuot Heat stress preconditioning and delayed myocardial protection: what is new? Cardiovasc Res, December 1, 2003; 60(3): 469 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Obal, H. Scharbatke, H. Barthel, B. Preckel, J. Mullenheim, and W. Schlack Cardioprotection against reperfusion injury is maximal with only two minutes of sevoflurane administration in rats: [La cardioprotection contre les lesions de reperfusion est maximale apres deux minutes seulement d'administration de sevoflurane chez des rats] Can J Anesth, November 1, 2003; 50(9): 940 - 945. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |